• Ability to test multiple sample types using PCRs, including urine, tissue, breast milk, cerebral spinal fluid, in addition to blood.
• Especially useful for seronegative patients.
• PCRs are detecting the DNA of the bacteria itself. Therefore, a positive result is definitive.
• Enables accurate identification of biochemically unusual strains of pathogen.
• Facilitates much earlier detection of the microorganism because the assay is independent of the host’s immune response schedule. Therefore, PCRs are useful for seronegative patients as well.
• Allows monitoring of the efficacy of an antibiotic regime.
RF Borrelia Genus (detects RF Borrelia species including B. hermsii, B. turicatae, B. miyamotoi, B. parkeri, B. coriaceae, B. turcica, and B.
recurrentis)
Positive: RF Borrelia DNA was detected.
Negative: RF Borrelia DNA was not detected in the sample analyzed.
RF Borrelia Subgroup Species (detects B. turicatae, B. miyamotoi, B. parkeri, B. coriaceae and B. recurrentis)
Positive: RF Borrelia species DNA was detected.
Negative: RF Borrelia species DNA was not detected in the sample analyzed.
- Results should be interpreted in conjunction with other laboratory and clinical findings.
- Test results can only help the physician in confirming clinical diagnosis.
- Not yet available for NY Residents
An inhibition study was performed on about 2000 clinical samples that included fresh whole blood, fresh serum, frozen urine and frozen CSF samples, according to NYS guidelines. It is clear that for all sample types tested, inhibition is well controlled and only occurred in less than 1% of samples. Therefore, no inhibition control is included in the assay.